SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-046120
Filing Date
2021-11-24
Accepted
2021-11-24 21:09:25
Documents
1
Period of Report
2021-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4029
  Complete submission text file 0000899243-21-046120.txt   5633
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Issuer) CIK: 0001095981 (see all company filings)

IRS No.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address MOLECULAR INSIGHT PHARMCEUTICALS, INC. 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
LaFrance Norman D. (Reporting) CIK: 0001397768 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34375 | Film No.: 211448928